The illustrative example below from the deck of Oliver Wyman's life sciences team shows how drugmakers can combine a range of services to meet the needs of patients, providers, and payers simultaneously in a holistic, integrated fashion.
This illustrative example from the deck of Oliver Wyman's life sciences team shows how drugmakers can combine a range of services to meet the needs of patients, providers, and payers simultaneously in a holistic, integrated fashion.
The illustrative example below from the deck of Oliver Wyman's life sciences team shows how drugmakers can combine a range of services to meet the needs of patients, providers, and payers simultaneously in a holistic, integrated fashion.
Infographic: Making Sense of MACRA
An explanation of the new healthcare provider payment tracks laid out under the Medicare Access and CHIP Reauthorization Act of 2015.
8 Million Nuclear Stress Tests are Performed in the US. Is This Necessary?
Nuclear stress tests expose patients to toxic radiation levels. We found 18 percent of physicians order them over 75 percent of the time.
Payer + Provider Partnerships (1/3): How Do Partnered Products Speed Transformation to Value?
This post is the first in a series of three this week based on a new Oliver Wyman report that explores in-depth how
COVID-19 Unveils a Payer Opportunity
Sixty-five percent of health plans with total membership in group commercial are at high-risk for negative profitability.